Molecule Structure

Scientific Name

Pindolol

Description of the Drug

Pindolol is a beta adrenoceptor antagonist used to treat hypertension, edema, ventricular tachycardias, and atrial fibrillation.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00960

Brand Name(s)

Betadren, Pindolol, Visken

Company Owner(s)

Nostrum Laboratories Inc, Sun Pharmaceutical Industries Inc, Idt Australia Ltd, Watson Laboratories Inc, Bayshore Pharmaceuticals Llc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Novartis Pharmaceuticals Corp, Zydus Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Beta-1 adrenergic receptor SINGLE PROTEIN PARTIAL AGONIST CHEMBL213
Beta-2 adrenergic receptor SINGLE PROTEIN PARTIAL AGONIST CHEMBL210

Unichem Links

SureChEMBL SCHEMBL5219
PharmGKB PA450966
Human Metabolome Database HMDB0015095
DrugBank DB00960
PubChem: Thomson Pharma 14749780
PubChem 4828
Mcule MCULE-7764948919
LINCS LSM-1953
Nikkaji J3.439H J457.020K J246.149H
BindingDB 50019443
EPA CompTox Dashboard DTXSID8023476
DrugCentral 2176
ChemicalBook CB3105373
Guide to Pharmacology 91
rxnorm PINDOLOL
PubChem: Drugs of the Future 24714739
KEGG Ligand C07445
ChEBI 8214